British drugmaker AstraZeneca plans to increase its investment in Egypt by 50 percent in the next three years, its country chief executive said on Monday.
The money will go for boosting AstraZeneca Egypt’s plant in the 6th of October City, Hatem Al-Wardani told Amwal Al Ghad.
Built in 2006 on a space over 6,500 metres square, the company’s plant produces blood pressure and diabetes drugs.
“We are studying adding new production lines using the latest technologies to manufacture new drugs for diabetes and tumours as well as working to produce new vaccines in the coming period.” Al-Wardani said.
“Carrying out this plan will definitely make Egypt one of the biggest countries in Africa and the Middle East where AstraZeneca invests,”
AstraZeneca Egypt has been one of the fastest-growing firms in the past two years, making a double-digit growth annually, the official added.
